Objective: We inspected the relevance of CD44, ABCB1 and ADAM17 in OSCC stemness and deciphered the role of autophagy/mitophagy in regulating stemness and chemoresistance. 
| INTRODUCTION
Regardless of the development in early detection, diagnosis and multimodal treatment strategies, oral squamous cell carcinomas (OSCC) is often associated with a high rate of locoregional recurrence, ipsilateral and bilateral lymph node metastasis and chemo-and radioresistance. 1 The marginal improvement in the overall 5-year survival rate of the OSCC patients and the inefficacy of the cotemporary adjuvant chemoradio-therapeutics is now been ostensible to the arbitrary cytoreductive approaches that are designed to target bulk tumour cells setting aside a small subset of resistant tumour cells which could propagate the tumour post-treatment. This resistant subpopulation of cells with exclusive self-renewal capacity, hierarchical differentiation and tumorigenicity is referred as Cancer Stem Cells (CSCs). 2 Autophagy is an evolutionary conserved lysosome-dependent selfdigestive recycling mechanism for providing metabolite for biosynthesis and energy synthesis as a response to stress conditions. Although autophagy functions as a tumour suppressor mechanism, it also shows protumour activity to facilitate cell survival during cancer progression. 2 Substantial studies suggest the significant contribution of autophagy in the resistance of tumour cells to chemotherapy. 3 Moreover, increased autophagic flux is also reported to induce resistance against therapyinduced cytotoxicity via maintaining the survival of CSCs through conferring stress tolerance and limiting damages. 2 Recently, the concept selective autophagy came forward which emphasizes role of organellar autophagy like selective mitochondrial autophagy or "Mitophagy"
in the context of cancer. The failure to properly modulate mitochondrial quality control via mitophagy in response to oncogenic stresses might regulate the tumorigenesis both positively and negatively. 4, 5 Furthermore, chemoresistant cancer cells are reported to exhibit stem cell-like features. 6 This study elucidates the role of autophagy in inducing stemness and chemoresistance in oral cancer.
CD44, most commonly studied CSC surface marker in oral cancer, is a transmembrane receptor which binds with hyaluronic acid (HA) and signals many cancer-related events such as proliferation, invasion and metastasis. CD44 is also associated with apoptosis resistance, drug resistance and stemness. 7 The ABCB1 subfamily of ABC transporters or the P-glycoproteins responsible for reduced intracellular accumulation of chemotherapeutics is highly expressed in CSCs. But the expressions of ABCB1 in oral cancer are not well studied. 8 ADAM17 (A disintegrin and metalloproteinase) or TACE (TNF-alpha converting enzyme), a membrane protein responsible for the cleavage CD44 ectodomain, extracellular matrix remodelling, invasion and metastasis of cancer, is also associated with inducing stemness and driving tumorigenesis in head and neck cancer. 9 The purpose of this study is to investigate the 
| MATERIALS AND METHODS

| Patients and tumour specimen
Archival formalin-fixed and paraffin-embedded (FFPE) tumour specimens from sixty cases of OSCC were collected from Drs. Tribedi and Roy Diagnostic Laboratory, Kolkata, local hospitals, nursing homes and clinics near the Ranchi area and Bangalore, India. The material had been stored with permission of the local ethics committee after informed consent obtained from the patients prior to surgical resection. Tumour and patient characteristics are summarized in Table S1 .
The tumour blocks of paraffin-embedded tissue were selected by experienced pathologists, evaluating the routine H.E.-stained sec- 
| Assessment standard
Each stained tumour specimen was photographed for 6 randomly selected fields with Olympus IX71 microscope, and all assessment were made at a magnification of ×200. The average of their evaluations was calculated for statistical analysis. Each slide was evaluated independently by 2 independent observers who did not know the clinical outcomes. The expression of each antibody was evaluated for each tissue sample by calculating the total Immuno-reactive Score (IRS) as the product of the proportion and intensity scores. The proportion score reflected the estimated fraction of positive-stained tumour cells (0, none; 1, 1%-25%; 2, 26%-50%; 3, 51%-75%; 4, 76%-100%). The intensity score represented the estimated staining intensity (0, no staining; 1, weak/light yellow; 2, moderate/buffy; 3, strong/brown). 10 The total IRS ranged from 0 to 12, and the scores were averaged. Scores of 0-5 were designated as low expression, while scores of 6-12 were designated as high expression. Moreover, IRS scores: 0 is considered (−); 1 to 4 (+); 5 to 8 (++); and 9 to 12 (+++).
| Cell culture
The human hypopharyngeal cancer cell line FaDu was procured from
American Type Culture Collection ([ATCC] , Manassas, USA). FaDu cells were cultured in MEM complemented with 10% fetal bovine serum and antibiotic-antimycotic solution followed by incubation at 37°C in a humidified (95% air: 5% CO 2 ) incubator.
| Establishment of CDDP resistance in OSCC cell line
FaDu cells were repeatedly subcultured in MEM containing increasing concentrations cis-Diammineplatinum (II) dichloride (CDDP/cisplatin) (Sigma-Aldrich, St. Louis, MO, USA) over a 3-month period. FaDu cells that grew in 0.5 μM CDDP were designated as FaDu CDDP resistant (FaDu CDDP-R) and maintained in MEM containing 0.5 μM cisplatin, whereas the parental FaDu cells were designated as FaDu-P.
| Drug sensitivity assay
FaDu-P and FaDu-CDDP-R cell concentration was adjusted to 5 × 10 4 cells/mL, plated in 96-well flat-bottom culture plates and incubated with various concentrations of CDDP for 72 h. The effect of CDDP on cancer cell viability was studied using MTT dye reduction assay by measuring the optical density at 595 nm using a micro-plate reader spectrophotometer (Perkin-Elmer, Walthman, MA, USA). 
| Sphere formation assay
| Immunocytofluorescence staining and analysis
| Western blot
Samples containing equal amounts of protein were subjected to SDS- 
| Statistical analysis
The data are presented as the mean ± SD. Statistical comparisons between subgroups were made using the appropriate statistical test (chisquare, chi-square for linear trend tests and Fisher exact test). The correlation between the marker proteins was analysed by Spearman rank test. Student's t test was used for evaluating statistical differences between experimental groups. The analysis was performed by GraphPad Prism 4.0 software. A 2-tailed P-value test was used in all analyses, and the P value was defined as follows: not significant (n.s.):
P > 0.05;*: P ≤ 0.05; **: P ≤ 0.01; ***: P ≤ 0.001; ****: P ≤ 0.0001 were considered statistically significant.
| RESULTS
| Clinical presentation of disease in this cohort
Numerous clinical characteristics of our cohort are described in and 73.68% (14/19), respectively. The CD44, ABCB1 and ADAM17 high expression in Grade III (poorly differentiated) OSCC tumours were 100% (9/9), 88.88% (8/9) and 88.88% (8/9), respectively, which were considerably high than Grade I and Grade II OSCC tumours with all P < 0.05 (P = 0.0129, P = 0.0001, P = 0.0026). However, expression profiles of CD44, ABCB1 and ADAM17 did not associate with age and sex of the patients (P all > 0.05) ( Table 1) .
Next, we investigated whether there is any link between CD44, ABCB1 and ADAM17 with STRING 10.5 (https://string-db.org/)
protein-protein interaction online software. Protein-protein interaction (PPI) enrichment P-value for CD44, ABCB1 and ADAM17 interaction is 0.00523, indicating that these proteins have more interactions
among themselves than what would be expected for a random set of proteins of similar size, drawn from the genome ( Figure S1 ). From the statistical analysis, we found a positive correlation between CD44 (or ADAM17) and ABCB1, as well as between CD44 and ADAM17 in OSCC. The CD44 and ABCB1 share a moderate positive correlation (Spearman correlation coefficient or r s : 0.574), whereas CD44 and ADAM17 and CD44 and ABCB1 share a weak positive relation with r s 0.428 and 0.346, respectively, all P < 0.01) (Table S3) . Furthermore, pairwise correlation analysis of these 3 proteins shows that the high expression of CD44/ABCB1, CD44/ADAM17 and ABCB1/ADAM17
was correlated with tumour grades and tumour differentiation (all P < 0.05). Also, the pairwise correlation analysis of these 3 proteins did not show a relationship with age and sex of the patients (all P > 0.05) (Table 2 ). Further, we analysed the correlation between the triple high expression (tissue samples having high expression status for all 3 proteins) and triple non-high expression (tissue sample having at least one low expression status among the 3 proteins). It is observed that triple high expression of CD44/ABCB1/ADAM17 was remarkably correlated with tumour grades and tumour differentiation (all P < 0.05).
However, it did not show any relation with age and sex of the patient (all P > 0.05) ( Table 3) .
To evaluate the hypothesis that putative CD44 + CSC are associated is reported that mild therapeutic stress can induce stem-like, drugtolerant stress-response states. 13 To further investigate the effect of CDDP exposure on acquisition of stemness in OSCC, the FaDu-P and FaDu-CDDP-R cells were plated onto ultralow attachment plates and sphere forming activity was observed and quantified after for 10 days.
Notably, the resistant FaDu cells produced larger spheres than the parental FaDu cells ( Figure 2B ). We further noticed that FaDu-CDDP-R formed more orospheres (117 ± 11) when cultured in ultralow attachment plates, as compared with the parental FaDu P cells (44 ± 5) ( Figure 2C ). Furthermore, we analysed the expression of stemness marker and self-renewal marker β-catenin expression in both resistant and parental cell line through immunofluorescence microscopy and detected that FaDu-CDDP-R cells displayed higher β-catenin expression than the FaDu-P cell ( Figure 2D ). Figure 2E 
| CDDP-mediated autophagy regulates stemness of resistant cancer cells and expression of CD44, ABCB1 and ADAM17
Next, we investigated the autophagic response in FaDu-P and FaDu-CDDP-R cells. From the immunofluorescence analysis, we found augmented formation of punctate structure of LC3, a hallmark of autophagy induction in FaDu-CDDP-R cells with FaDu-P cells showed a diffused LC3 fluorescence with lesser puncta ( Figure 3A ).
Approximately 24 ± 1.8% FaDu-P cells displayed LC3B-II puncta per cell, whereas it increased to 57 ± 5.9% in FaDu-CDDP-R cells ( Figure 3B ). Next, we evaluated the extent of autophagosome and autolysosome formation in terms of fluorescent LC3 puncta. Both the numbers of GFP and RFP puncta per cell were found in remarkable amount in FaDu-CDDP-R cells ( Figure 3C ). The number of RFP + GFP + (yellow) puncta was considerably higher in FaDu-CDDP-R cells indicating increased autophagosome formation ( Figure 3C,D) .
Moreover, augmented autolysosome formation and higher au- To further substantiate our hypothesis that mitophagy plays a significant role in chemoresistance, we assayed functional mitophagy by using mitochondria-targeted mKeima-Red-Mito7, a lysosomal proteases resistant probe whose fluorescence shifts from green to red in acidic pH as an indicative of the mitochondrial delivery into T A B L E 3 Relationship between triple high expression and triple non-high expression of CD44/ABCB1/ADAM17 and the clinicopathological features of OSCC Five cases of OSCC patients without gender details; 11 cases of OSCC patients without age details.
****P ≤ .0001. . Western blot analysis of autophagic protein LC3B, ULK1, Beclin1, ATG5, ATG7, ATG14 and p62 is depicted (E). Western blot image depicts the down regulation of ATG14 with transient transfection of siATG14 in FaDU-P and FaDu-CDDP-R cells (F). Immunofluorescence analysis of LC3B-II puncta formation in FaDU-P and FaDu-CDDP-R cells in siControl and siATG14 transfected condition were evaluated (G). % of LC3B-II puncta positive cells in siControl and ATG14-deficient FaDU-P and FaDu-CDDP-R cells was quantified (H). Densitometry was performed on the original blots; the ratio of protein to actin in control cells was considered as 1. **P value < 0.01 was considered significant when compared between FaDu-P and FaDu-CDDP-R group. ## P value < 0.01 was considered significant when compared between FaDu-CDDP-R and siATG14-FaDu-CDDP-R in FaDu-CDDP-R cells was found to effectively down regulate the stemness surface marker CD44 ( Figure 5D ,E) along with the down regulation of drug resistance marker ABCB1 (Figure 5F ,G) and invasion mediator ADAM17 ( Figure 5H,I ), suggesting that autophagy regulates the expression of these proteins to induce stemness and chemoresistance. However, further study is required to understand how autophagy modulates the expression CD44, ABCB1 and ADAM17 during chemoresistance.
F I G U R E 2
| DISCUSSION
Most of the cotemporary therapeutic regimens target only the bulk tumour mass leaving behind the assassin CSCs that serve as a reservoir for tumour repopulation post-therapy. Likely, CSCs in oral cancer were reported to impose a great therapeutic implication in cancer relapse and patient survival.
14 A correlation between CD44 expression and poor prognosis has been reported in many cancers. 15, 16 Moreover, CD44 may also symbolize a potential marker of OSCC stem cells. 17, 18 This study confirms the expression of stem cell surface marker CD44 expression in OSCC tissue samples.
Moreover, CD44 expression in OSCC was found to be associated with tumour grade and tumour differentiation. Again, CSCs have been postulated to be drug resistance phenotypes by virtue of the expression of several drug efflux transporters. 19, 20 Previous study showed that expression of ABCB1 marker correlates with the degree of differentiation in gastric cancer. 8 Similarly, in our study, the expression of ABCB1 highly correlated with the degree of differentiation of OSCC tissue. Moreover, the upregulated expression of ADAM17 was shown to be associated with poor prognosis of F I G U R E 4 Mitophagy regulates chemoresistance in FaDu cells. Immunofluorescence expression (A) and quantification of outer mitochondrial marker protein TOM20 in FaDU-P and FaDu-CDDP-R (B) were analysed. Western blot analysis of inner mitochondrial marker protein COX-IV was investigated (C). The mitochondrial delivery to lysosome in order to measure the mitophagic flux (in terms of increased red puncta) was assayed by employing mKeima-Red-Mito7 (D and E). Immunofluorescence expression of TOM20 with quantification of % of cells with less/ no mitochondrial TOM20 staining in FaDU-P and FaDu-CDDP-R cells after transient transfection of siControl and siATG14 are depicted (F and G). Western blot analysis of COX-IV expression in ATG14-deficient FaDU-P and FaDu-CDDP-R cells is represented (H). Densitometry was performed on the original blots, the ratio of protein to actin in control cells was considered as 1. **P value < 0.01 was considered significant when compared between FaDu-P and FaDu-CDDP-R groups.
##
P value < 0.01 was considered significant when compared between FaDu-CDDP-R and siATG14-FaDu-CDDP-R cancers. 21 
Autophagy regulates stemness and expression of CD44, ABCB1 and ADAM17 in CDDP-resistant FaDu cells. After knock down of ATG14, FaDu P and FaDu CDDP-R cells were grown in ultralow attachment plate in stem cell media for 10 days and the number orospheres produced were quantified (A). Immunofluorescence analysis of β-catenin, CD44, ABCB1 and ADAM17 in ATG14-deficient FaDU-P and FaDu-CDDP-R cells and their corresponding quantification was analysed (B-I). **P value < 0.01 was considered significant when compared between FaDu-P and FaDu-CDDP-R group. ## P value < 0.01 was considered significant when compared between FaDu-CDDP-R and siATG14-FaDu-CDDP-R emphasized the role of these proteins in chemoresistance. Likely, chemoresistance in colon carcinoma cells was reported to be mediated by CD44 survival signalling via Lyn Kinase and phosphoinositide 3-kinase/Akt. 27 In addition, it reported that CD44 expression was associated with chemoresistance in T-cell acute lymphoblastic leukaemia mediated in part through enhanced drug efflux system.
28
The chemoresistance in CSCs is mainly alleged to the higher expression of ABC drug efflux transporters. 2 The expression of ABCB1 in colorectal cancer has been shown to promote stemness and chemoresistance. 29 In consistent with the previous report, 9 ADAM17
expression was also reported to be involved in stemness and chemoresistance in OSCC. it has been shown that JAK-mediated autophagy is responsible for maintenance of stemness in cisplatin-resistant bladder cancer cells. 6 Moreover, in urothelial carcinoma cells, gemcitabine-and mitomycin-induced autophagy was also found to regulate cancer stem cell pool. 33 In accordance with previous studies and validating our hypothesis, the present investigation documents the au- and multidrug resistance which is in agreement with this study involving the autophagic regulation of ABCB1-mediated drug resistance in oral cancer. However, paradoxically, it has been found that both autophagy inhibitor and inducer enhanced the activity of α secretases like ADAM10 and ADAM17. 39 Moreover, it has also been described that ADAM17 inhibitor, TIMP3 reduction causes a concomitant STAT1-dependent loss of FoxO1 activity, which consequentially diminishes protective autophagy genes to fuel glomeruli damage suggesting the prospective association of ADAM17 and autophagy process. 40 Accordingly, autophagy was shown to regulate the expression of ADAM17 in resistant FaDu cells which is a key molecule in the process of carcinogenesis and metastasis. As reported earlier, CDDP induces Mitochondrial-ROS
Response that leads to mitochondrial dysfunction as a part of its cytotoxicity. 41 Dysfunctional mitochondria are a hub of ROS generation which is encountered by selective clearance of reactive mitochondria through mitophagy. 42 The basal level of mitophagy 
